Skip to content
PICO Portalanswers from OpenAlex

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>

PaperCitations, authors & open-access status

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is a paper indexed in PICO Portal from OpenAlex.

How many citations does Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> have?

PICO Portalcitation count

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> has 144 citations in the OpenAlex counts PICO Portal stores.

When was Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> published?

PICO Portalyear

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> has 2002 year in the PICO Portal index.

What is the open-access status of Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

PICO Portaloa status

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> has green oa status in the PICO Portal index.

What is the DOI of Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

PICO Portaldoi

The DOI for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is on the source record.

What is the PMID of Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

PICO Portalpmid

The PMID for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is on the source record.

What is the OpenAlex record for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

PICO Portalopenalex

The OpenAlex for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial